PRESS RELEASE published on 08/14/2023 at 12:30, 1 year 3 months ago iFabric Corp Matches Record Revenues of $5.3 Million for Q3 2023
PRESS RELEASE published on 07/05/2023 at 12:30, 1 year 4 months ago iFabric Corp Announces the Successful Results of the Clinical Trial Utilizing Protx2 Treated Scrubs
PRESS RELEASE published on 06/13/2023 at 12:30, 1 year 5 months ago iFabric Corp Announces Issuance of New United States Utility Patent for Antiviral Applications on Textiles
PRESS RELEASE published on 05/15/2023 at 12:30, 1 year 6 months ago iFabric Corp Reports a Record 91% Increase in Second Quarter Revenues
PRESS RELEASE published on 05/02/2023 at 12:30, 1 year 6 months ago iFabric Corp Announces Breakthrough in EPA Public Health Claims Approval Process With Initial Registration of PROTX2 for Use in Non-Apparel Products
PRESS RELEASE published on 03/31/2023 at 12:30, 1 year 7 months ago iFabric Announces 2023 Annual General Meeting Voting Results
PRESS RELEASE published on 03/16/2023 at 11:30, 1 year 8 months ago iFabric Corp Announces Exclusive License Agreement with Les Innovation Simon Chang
PRESS RELEASE published on 02/14/2023 at 12:30, 1 year 9 months ago iFabric Corp Announces Q1 2023 Financial Results
PRESS RELEASE published on 01/31/2023 at 12:30, 1 year 9 months ago iFabric Corp Announces EPA Registration of New Technology, bioACTIV AM
Published on 11/21/2024 at 14:00, 13 minutes ago Demotech, Inc. Assigns a Financial Stability Rating(R) of A, Exceptional, to Steadily Insurance Company
Published on 11/21/2024 at 14:00, 13 minutes ago Montara Raises $5.4M to Help Organizations Deliver Better Data Products Faster
Published on 11/21/2024 at 14:00, 13 minutes ago Tevir Capital LP Ltd. Updates Early Warning Reporting in Respect of VerticalScope Holdings Inc.
Published on 11/21/2024 at 13:30, 43 minutes ago AirIQ Announces September 30, 2024 Quarterly Results Company Reports Double-Digit Growth in Recurring Revenue
Published on 11/21/2024 at 12:35, 1 hour 38 minutes ago audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 1 hour 58 minutes ago Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 06:58, 7 hours 15 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 53 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 20 hours 28 minutes ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 20 hours 28 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 6 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo